Figures & data
Figure 1 Effect of cytokines (TNF-α, IL-1β and IFN-γ) on IP-10 and IL-8 protein release. Cytokine treatment increased IP-10 (circles) and IL-8 (triangles) protein in epithelial cell-conditioned medium at 12 hr (open symbols) and 24 hr (closed symbols) (p < 0.001 versus vehicle for both IP-10 and IL-8 at 12 and 24 hr). Mean ± SEM of 5 experiments.
![Figure 1 Effect of cytokines (TNF-α, IL-1β and IFN-γ) on IP-10 and IL-8 protein release. Cytokine treatment increased IP-10 (circles) and IL-8 (triangles) protein in epithelial cell-conditioned medium at 12 hr (open symbols) and 24 hr (closed symbols) (p < 0.001 versus vehicle for both IP-10 and IL-8 at 12 and 24 hr). Mean ± SEM of 5 experiments.](/cms/asset/164aa8ab-6a2e-4118-bc41-78bc8ba0fa33/icop_a_281835_uf0001_b.gif)
Figure 2 Effect of cytokines (TNF-α, IL-1β and IFN-γ) on IP-10 and IL-8 mRNA expression. Cytokine treatment increased IP-10 and IL-8 mRNA at 12 hr (black bars) and 24 hr (gray bars) as measured by real time RT-PCR. IP-10 and IL-8 mRNA are expressed as fold-change from control, where fold-change = 2 (control ct–chemokine ct). Mean ± SEM of 2–3 experiments.
![Figure 2 Effect of cytokines (TNF-α, IL-1β and IFN-γ) on IP-10 and IL-8 mRNA expression. Cytokine treatment increased IP-10 and IL-8 mRNA at 12 hr (black bars) and 24 hr (gray bars) as measured by real time RT-PCR. IP-10 and IL-8 mRNA are expressed as fold-change from control, where fold-change = 2 (control ct–chemokine ct). Mean ± SEM of 2–3 experiments.](/cms/asset/15817e10-d3f2-42d0-9bbc-da2694f3de99/icop_a_281835_uf0002_b.gif)
Figure 3 Effect of fluticasone on cytokine-induced IP-10 and IL-8 protein. Fluticasone dose-dependently increased IP-10 (Panel A) and decreased IL-8 (Panel B) protein in cytokine-stimulated, airway epithelial cell-conditioned medium at 24 hr (p < 0.001 by 1-way RM ANOVA for both). Chemokine protein expressed as percent of control, i.e., cytokine-treated cells. Mean ± SEM of 5 experiments for each.
![Figure 3 Effect of fluticasone on cytokine-induced IP-10 and IL-8 protein. Fluticasone dose-dependently increased IP-10 (Panel A) and decreased IL-8 (Panel B) protein in cytokine-stimulated, airway epithelial cell-conditioned medium at 24 hr (p < 0.001 by 1-way RM ANOVA for both). Chemokine protein expressed as percent of control, i.e., cytokine-treated cells. Mean ± SEM of 5 experiments for each.](/cms/asset/97cd31a1-2f5b-4d91-8cd9-dedebb8f00da/icop_a_281835_uf0003_b.gif)
Figure 4 Effect of fluticasone on cytokine-induced IP-10 and IL-8 mRNA. Fluticasone (12 hr) had no significant effect on IP-10 (p = 0.54) (Panel A) but reduced IL-8 mRNA (p < 0.04) (Panel B), as assessed by real-time RT-PCR. Mean ± SEM of 5 experiments.
![Figure 4 Effect of fluticasone on cytokine-induced IP-10 and IL-8 mRNA. Fluticasone (12 hr) had no significant effect on IP-10 (p = 0.54) (Panel A) but reduced IL-8 mRNA (p < 0.04) (Panel B), as assessed by real-time RT-PCR. Mean ± SEM of 5 experiments.](/cms/asset/ab7a6b32-1831-4f42-9a47-a0b36ed6401e/icop_a_281835_uf0004_b.gif)
Figure 5 Effect of salmeterol and cilomilast on cytokine-induced IP-10 protein. Cells were stimulated with cytokines for 24 hr. Addition of cilomilast alone (0, 1 μ M, 10 μ M-open bars) during this time (24 hr) had no effect on IP-10. The addition of salmeterol (1 μ M for 24 hr-closed bars) to cilomilast inhibited IP-10 (* p = 0.013 by 1-way RM ANOVA). Mean ± SEM of 3 experiments.
![Figure 5 Effect of salmeterol and cilomilast on cytokine-induced IP-10 protein. Cells were stimulated with cytokines for 24 hr. Addition of cilomilast alone (0, 1 μ M, 10 μ M-open bars) during this time (24 hr) had no effect on IP-10. The addition of salmeterol (1 μ M for 24 hr-closed bars) to cilomilast inhibited IP-10 (* p = 0.013 by 1-way RM ANOVA). Mean ± SEM of 3 experiments.](/cms/asset/84667d7b-d20d-438a-9543-7e9ce87ec594/icop_a_281835_uf0005_b.gif)
Figure 6 Effect of salmeterol or dibutyryl cAMP on fluticasone-induced IP-10 and IL-8 Protein. Panel A: Cells were stimulated with cytokines for 24 hr. Addition of salmeterol (1 μ M-solid bars) or db-cAMP (1 mM-cross-hatched bars) during this time (24 hr) inhibited fluticasone-induced (10− 10 M-open bars) increases in IP-10 protein (* p = 0.013 for salmeterol and ** p < 0.001 for db-cAMP by 2-way RM ANOVA). Mean ± SEM of 3 experiments. Panel B: Neither salmeterol (solid bars) nor db-cAMP (cross-hatched bars) affected fluticasone-induced (open bars) decreases in IL-8 protein (p = 0.97 for salmeterol and p = 0.10 for db-cAMP by 2-way RM ANOVA). Mean ± SEM of 3 experiments.
![Figure 6 Effect of salmeterol or dibutyryl cAMP on fluticasone-induced IP-10 and IL-8 Protein. Panel A: Cells were stimulated with cytokines for 24 hr. Addition of salmeterol (1 μ M-solid bars) or db-cAMP (1 mM-cross-hatched bars) during this time (24 hr) inhibited fluticasone-induced (10− 10 M-open bars) increases in IP-10 protein (* p = 0.013 for salmeterol and ** p < 0.001 for db-cAMP by 2-way RM ANOVA). Mean ± SEM of 3 experiments. Panel B: Neither salmeterol (solid bars) nor db-cAMP (cross-hatched bars) affected fluticasone-induced (open bars) decreases in IL-8 protein (p = 0.97 for salmeterol and p = 0.10 for db-cAMP by 2-way RM ANOVA). Mean ± SEM of 3 experiments.](/cms/asset/081c813b-b912-42e3-aa38-22994d9883d8/icop_a_281835_uf0006_b.gif)